NTAP vs PACB · P/E 28, rev $6.57B vs rev $38.4M
NetApp Inc (NTAP) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. PACB currently screens at market cap $387.1M.
Not investment advice. Open the NTAP and PACB stock pages for the full models.
Not investment advice.